Methods and Techniques to Facilitate the Development of <i>Clostridium novyi</i> NT as an Effective, Therapeutic Oncolytic Bacteria.

Dailey, Kaitlin M; Jacobson, Reed I; Johnson, Paige R; Woolery, Taylor J; Kim, Jiha; Jansen, Rick J; Mallik, Sanku; Brooks, Amanda E

Methods and Techniques to Facilitate the Development of Clostridium novyi NT as an Effective, Therapeutic Oncolytic Bacteria.

Dailey, Kaitlin M; Jacobson, Reed I; Johnson, Paige R; Woolery, Taylor J; Kim, Jiha; Jansen, Rick J; Mallik, Sanku; Brooks, Amanda E.

Afiliación

Dailey KM; Cell and Molecular Biology Program, North Dakota State University, Fargo, ND, United States.
Jacobson RI; Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND, United States.
Johnson PR; Department of Biological Sciences, North Dakota State University, Fargo, ND, United States.
Woolery TJ; Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND, United States.
Kim J; Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND, United States.
Jansen RJ; Department of Biological Sciences, North Dakota State University, Fargo, ND, United States.
Mallik S; Department of Public Health, North Dakota State University, Fargo, ND, United States.
Brooks AE; Genomics and Bioinformatics Program, North Dakota State University, Fargo, ND, United States.

Front Microbiol ; 12: 624618, 2021.

Article en En | MEDLINE | ID: mdl-33854487

Palabras clave

CRISPR(clustered regularly interspaced short palindromic repeat)/Cas9(CRISPR associated protein 9)-mediated genome editing; Clostridia; gene engineering; oncolytic bacteria; oncotherapeutics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Microbiol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos